DRTSW
Alpha Tau Medical Ltd - Warrants (07/03/2027) (DRTSW)
NASDAQ • $1.31+33.68%
- Symbol
- DRTSW
- Exchange
- NASDAQ
- Sector
- Industry
- Price
- $1.31
- Daily Change
- +33.68%
- Market Cap
- N/A
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $1.33
- 52W Low
- $1.03
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 1.12
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Company websiteResearch DRTSW on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.